jump to navigation jump to main content jump to footer

Jens Apermann

Member of the Supervisory Board

Year of birth: 1968
Nationality: German
Member since: End of the Annual General Meeting 2024
Elected until: End of the Annual General Meeting 2027

Membership in statutory supervisory boards and comparable national or foreign supervisory committees of commercial enterprises:
German seats:

  • Medios AG, Berlin (Member of the Supervisory Board)
  • easyApotheke (Holding) AG, Düsseldorf (Member of the Supervisory Board)
Portrait von Jens Apermann mit grauen Haaren und freundlichem Ausdruck

Jens Apermann studied law at the University of Hamburg and trained as a PR consultant/editor. After holding several positions in communications agencies and companies in Hamburg and Frankfurt/M., he became co-founder and Director of Marketing & Sales of the online pharmacy DocMorris, Netherlands, in 1999. 

After leaving DocMoriss, he founded what is now Pleja AG, Zurich, in 2004, a consulting and investment company in the healthcare sector. Mandates and investments in Germany and the Netherlands are primarily in the pharmacy sector, telemedicine and start-ups in the field of digital human and veterinary medicine. 

Due to his many years of practical experience in various roles as a generalist among specialists, Jens Apermann has a profound understanding of structures, players and interests in the healthcare sector.

Stay Informed

Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.

Registration is free of charge and can be revoked at any time.

Click here to register

Claudia Nickolaus
Head of Investor & Public Relations ESG Communications   

+49 30 232 566 800   
ir@medios.group

About Medios

Specialty Pharma

People & Career

Important Notice!

We have been informed of a fake listing of a cosmetic product on the TEMU platform in which Medios is falsely named as the distributor. Unfortunately, such unauthorized product listings are repeatedly observed on unreliable platforms like TEMU.

We would like to clarify: This offer is in no way connected to Medios and is not authorized. Our legal department has been informed.

Please obtain medical products exclusively through authorized and verified sources.

If you have any further questions, please contact: ir@medios.group

Back to Top